The Chennai lab extends PerkinElmer’s capabilities in India with a widened set of assays related to cytogenetics and molecular diagnostics
PerkinElmer has launched a new diagnostics facility in Chennai, Tamil Nadu. Reportedly, the laboratory will provide a comprehensive menu of diagnostic screening services to hospitals, maternity nursing facilities, diagnostic labs and clinicians throughout India.
Prahlad Singh, President, Diagnostics, PerkinElmer formally inaugurated the facility in the presence of a leading group of clinicians, including gynaecologists, fetal medicine specialists and pediatricians, along with medical research professionals and key opinion leaders.
“We are experiencing a steady rise in demand for maternal fetal health and newborn screening solutions in India as hospitals, clinicians and expectant parents strive to ensure healthier outcomes through early detection, diagnosis and proper management of prenatal and neonatal conditions,” said Jayashree Thacker, President, PerkinElmer India. “This state-of-the art laboratory underscores our commitment to our continued expansion plans in India. By increasing our capacity to accommodate higher testing volumes, offer a comprehensive and growing menu of diagnostic assays, and provide a hands-on experience with our innovative technologies, we are further supporting India’s healthcare requirements,” she added.
The Chennai laboratory extends PerkinElmer’s capabilities in India with a widened set of assays related to cytogenetics and molecular diagnostics. PerkinElmer will also provide customer service and support, along with product training and demonstrations, at the Chennai laboratory, informs a company release.